Mitoxantrone versus daunorubicin in induction-consolidation chemotherapy - the value of low dose cytarabine for maintenance of remission, and an assessment of prognostic factors in acute myeloid leukemia in the elderly: final report. European Organization of Cancer and the Dutch-Belgian Hemato-Oncology Cooperative Hovon Group. - Loewenberg,B.; Suciu,S.; Archimbaud,E.; Haak,H.; Stryckmans,P.; de Cataldo,R.; Dekker,A.W.; Berneman,Z.N.; Thyss,A.; van de Lelie,J.; Sonneveld,P.; Visani,G.; et al. (J Clin Oncol, 1998)